Guggenheim Maintains Buy on GH Research, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 62.2%

Neg 0% Neu 0% Pos 62.2%

Guggenheim analyst Eddie Hickman maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $34 to $40.